Desflurane for maintenance of anaesthesia | ES41 | | |
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults | ES40 | | |
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections | ES39 | | |
Melatonin for treating sleep disorders in adults who are blind | ES38 | | |
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia | ES37 | | |
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis | ES35 | | |
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections | ES32 | | |
Antimicrobial prescribing: imipenem with cilastatin and relebactam | ES30 | | |
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis | ES29 | | |
Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia | ES22 | | |
Antimicrobial prescribing: meropenem with vaborbactam | ES21 | | |
Opioid dependence: buprenorphine prolonged-release injection (Buvidal) | ES19 | | |
Mitochondrial disorders in children: Co-enzyme Q10 | ES11 | | |
Hyperhidrosis: oxybutynin | ES10 | | |
Narcolepsy with or without cataplexy in adults: pitolisant | ES8 | | |
Skin involvement in systemic sclerosis: rituximab | ES7 | | |
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | | |
Refractory extrapulmonary sarcoidosis: infliximab | ES4 | | |
Pulmonary sarcoidosis: infliximab | ES2 | | |
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | | |
Complicated urinary tract infections: ceftolozane/tazobactam | ESNM74 | | |
Complicated intra-abdominal infections: ceftolozane/tazobactam | ESNM75 | | |
Reversal of the anticoagulant effect of dabigatran: idarucizumab | ESNM73 | | |
Chronic wounds: advanced wound dressings and antimicrobial dressings | ESMPB2 | | |
Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetron | ESNM69 | | |
Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream | ESNM68 | | |
C3 glomerulopathy in the native kidney: eculizumab | ESUOM49 | | |
Restless legs syndrome: Oxycodone/naloxone prolonged release | ESNM67 | | |
External genital and perianal warts: green tea (Camellia sinensis) leaf extract 10% ointment | ESNM66 | | |
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) | ESNM65 | | |
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) | ESNM64 | | |
Coronary revascularisation: Cangrelor | ESNM63 | | |
Orthostatic hypotension due to autonomic dysfunction: midodrine | ESNM61 | | |
Infantile haemangioma: topical timolol | ESUOM47 | | |
Hypersexuality: fluoxetine | ESUOM46 | | |
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) | ESNM60 | | |
Symptoms of peripheral arterial disease: ramipril | ESUOM45 | | |
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumab | ESUOM44 | | |
Digital ulcers: sildenafil | ESUOM42 | | |
Clostridium difficile infection: risk with broad-spectrum antibiotics | ESMPB1 | | |
Autoimmune haemolytic anaemia: rituximab | ESUOM39 | | |
Erectile dysfunction: Alprostadil cream | ESNM50 | | |
Immune (idiopathic) thrombocytopenic purpura: rituximab | ESUOM35 | | |
Management of vomiting in children and young people with gastroenteritis: ondansetron | ESUOM34 | | |
Promoting tolerance of enteral feeds in children and young people: domperidone | ESUOM18 | | |
Migraine prophylaxis: flunarizine | ESUOM33 | | |
Schizophrenia: lurasidone | ESNM48 | | |
Non-Hodgkin's lymphoma: rituximab subcutaneous injection | ESNM46 | | |
Erectile dysfunction: avanafil | ESNM45 | | |
Facial erythema of rosacea: brimonidine tartrate gel | ESNM43 | | |
Chronic urticaria: off-label doses of cetirizine | ESUOM31 | | |
Premature ejaculation: dapoxetine | ESNM40 | | |
Pouchitis: rifaximin | ESUOM30 | | |
Combined oral contraception: nomegestrol/estradiol (Zoely) | ESNM28 | | |
Bile acid malabsorption: colesevelam | ESUOM22 | | |
Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment | ESUOM21 | | |
Postural hypotension in adults: fludrocortisone | ESUOM20 | | |
Schizophrenia: omega-3 fatty acid medicines | ESUOM19 | | |
Type 2 diabetes: insulin degludec | ESNM25 | | |
Hyperhidrosis: oral glycopyrronium bromide | ESUOM16 | | |
Chronic anal fissure: botulinum toxin type A injection | ESUOM14 | | |
Gastroparesis in adults: oral erythromycin | ESUOM13 | | |
Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment | ESUOM7 | | |
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab | ESNM13 | | |
Polycystic ovary syndrome: metformin in women not planning pregnancy | ESUOM6 | | |
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate | ESUOM4 | | |
Chronic anal fissure: 2% topical diltiazem hydrochloride | ESUOM3 | | |